Solventum Corporation
SOLV Healthcare Medical Instruments & Supplies
Solventum Corporation’s revenue for fiscal 2025 (year ended December 2025) was $8.3 billion, up 0.86% from fiscal 2024. In the quarter to June 2026, revenue grew 2.22%, EPS grew 1.92%, free cash flow grew 144.1% and total debt fell 32.4%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for three consecutive years; insiders bought in the last twelve months.
Follow SOLV
Solventum Corporation (SOLV) Operating cash flow
Solventum Corporation's operating cash flow for fiscal 2025 was $369.0M, down 68.9% from $1.2B in fiscal 2024. Over the twelve months to 30 June 2026 it was $209.0M. Solventum Corporation ranks 19th of 54 Medical Instruments & Supplies companies by operating cash flow.
Operating cash flow, annual
Embed this chart
Annual newest first
| Period | Operating cash flow | Change |
|---|---|---|
| FY2025 | $369.0M | (68.86%) |
| FY2024 | $1.2B | (38.12%) |
| FY2023 | $1.9B | 14.06% |
| FY2022 | $1.7B | — |
Quarterly newest first
| Period | Operating cash flow | Change |
|---|---|---|
| Jun 2026 | $227.0M | — |
| Mar 2026 | −$189.0M | — |
| Dec 2025 | $95.0M | 25.00% |
| Sep 2025 | $76.0M | (55.03%) |
| 11 more quarters | Free account |
Operating cash flow against peers
| Company | Operating cash flow |
|---|---|
| ALC Alcon compare | $2.3B |
| BAX Baxter International Inc. compare | $1.3B |
| COO The Cooper Companies, Inc. compare | $1.0B |
| ALGN Align Technology, Inc. compare | $755.7M |
| WST West Pharmaceutical Services, Inc. compare | $662.2M |
| AVTR Avantor, Inc. compare | $597.0M |
| ATR AptarGroup, Inc. compare | $583.5M |
| SOLV Solventum Corporation | $209.0M |
| RGEN Repligen Corporation compare | $134.9M |
What Operating cash flow is
Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.
Reported line item
More on SOLV
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement